Characteristics of users and implications for the use of complementary and alternative medicine in Ghanaian cancer patients undergoing radiotherapy and chemotherapy: A cross- sectional study

BMC Complementary and Alternative Medicine

Volumn 13, Issue , 2013, Pages

  Yarney, Joel ^a   Donkor, Andrew ^a   Opoku, Samuel Y ^b   Yarney, Lily ^b   Agyeman Duah, Isaac ^a   Abakah, Alice C ^c   Asampong, Emmanuel ^b  

^a KORLE BU TEACHING HOSPITAL   (Ghana)

^b UNIVERSITY OF GHANA   (Ghana)

^c Department of Mathematics and Statistics ^*  (Ghana)

Author keywords

Alternative; Cancer; Chemotherapy; Complementary; Medicine; Radiotherapy; Toxicity; Traditional; User characteristics

Indexed keywords

ANTINEOPLASTIC AGENT; HERBACEOUS AGENT; VITAMIN;

ABDOMINAL CANCER; ADULT; AGED; ALTERNATIVE MEDICINE; ANOREXIA; ARTICLE; BLEEDING; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CHINESE MEDICINE; CROSS-SECTIONAL STUDY; DESCRIPTIVE RESEARCH; DIARRHEA; DIZZINESS; DRUG MEGADOSE; EDUCATIONAL STATUS; FEMALE; FRIEND; GASTROINTESTINAL SYMPTOM; GHANA; HEAD AND NECK CANCER; HEADACHE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MASS MEDIUM; MASSAGE; NAUSEA; NEOPLASM; PELVIS CANCER; PREDICTOR VARIABLE; PREVALENCE; PROSTATE CANCER; PRURITUS; QUESTIONNAIRE; RECTUM CANCER; RELIGION; STOMACH CANCER; STOMACH PAIN; UTERINE CERVIX CANCER;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COMPLEMENTARY THERAPIES; CROSS-SECTIONAL STUDIES; DRUG INTERACTIONS; EPIDEMIOLOGIC FACTORS; FEMALE; GHANA; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASMS; PALLIATIVE CARE; PHYSICIAN-PATIENT RELATIONS; QUESTIONNAIRES; SOCIOECONOMIC FACTORS; YOUNG ADULT;

EID: 84872326642     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-13-16     Document Type: Article

References (33)

1. Ernst E, Resch KL, Mills S, et al. Complimentary medicine- a definition. Br J Gen Pract 1995, 45:506. 1239385, 7546880.
2. Ernst E. Coplementary cancer treatment: hope or hazard?. Clin Oncol 1995, 7:259-263.
3. Commodore SGO Welcome address presented at " Traditional Medicine and Modern Health Care: Partnership for the Future, A Two-day National Consensus building Symposium on the Policies on Traditional Medicine in Ghana 1995, 15-16. Accra, Ghana, http://ebookbrowse.com/80-compendium-of-medicinal-and-aromatic-plants-africa-vol-i-pdf-d425614889: 26-30, 3271819, 20018098, Commodore SGO.
4. De Graft Aikins A, Anum A, Agyepong C, Addo J, Ogedegbe O. Lay representation of chronic disease in Ghana: implication for primary prevention. Ghana Med J 2012, 46(2):59-68.
5. Ferlay J, Bray F, Parkin DM. GLOBOCAN 2000: Cancer Incidence, Mortality and Prevalence Worldwide, Version 1.0. IARC Cancer Base No. 5 2001, Lyon: IARC Press.
6. Ries LAG, Melbert D, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2008 2008, Bethesda, MD: National Cancer Institute, http://seer.cancer.gov/cso/19752005/index,html.] (Accessed on 13/10/09).
7. Brenner H, Gondos A, Arndt V. Recent major progress in long-term cancer patient survival disclosed by modelled period analysis. J Clin Oncol 2007, 25(22):3274-3280. 10.1200/JCO.2007.11.3431, 17664474.
8. Campbell K. Leukemia Research, Complementary and Alternative Medicine 2007, Available online at URL; http://www.Irf.org.uk. (Accessed on 25/11/09).
9. Clegg- Lamptey J, Dakubo J, Attobra YN. Why do breast cancer patients report late or abscond during treatment in Ghana? A pilot study. Ghana Med J 2009, 43(3):127-131. 2810246, 20126325.
10. Miller DR, Anderson GT, Stark JJ, Granick JL, Richardson D. Phase I/II trial of the safety and efficacy of shark cartilage in the treatment of advanced cancer. J Clin Oncol 1998, 16:3649-3655.
11. Loprinzi CL, Levitt R, Barton DL, Sloan JA, Atherton PJ, Smith DJ, Dakhil SR, Moore DF, Krook JE, Rowland KM, Mazurczak MA, Berg AR, Kim GP, North Central Cancer Treatment Group Evaluation of shark cartilage in patients with advanced cancer; a North Central Cancer Treatment group trial. Cancer 2005, 104:176-182. 10.1002/cncr.21107, 15912493, North Central Cancer Treatment Group.
12. Lawenda BD, Kelly KM, Ladas EJ, Sagar SM, Vickers A, Blumberg JB. Should supplement antioxidant administration be avoided during chemotherapy and radiation therapy?. J Natl Cancer Inst 2008, 4:100(11).
13. Ezeome ER, Anarado AN. Use of complementary and alternative medicine by cancer patients at the University of Nigeria Teaching Hospital, Enugu, Nigeria. BMC Complement Altern Med 2007, 7:28. 10.1186/1472-6882-7-28, 2034592, 17850665.
14. Chang KH, Brodie R, Choong MA, Sweeney KJ, Kerin M. Complementary and alternative medicine use in oncology: a questionnaire survey of patients and health care professionals. BMC Cancer 2011, 11:196. 10.1186/1471-2407-11-196, 3123324, 21609461.
15. Richardson MA, Sanders T, Palmer JL, Greisinger A, Singletary SE. Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol 2000, 18(13):2505-2514.
16. Molassiotis A, Fernadez-Ortega P, Pud D, Ozden G, Scott JA, Panteli V, Margulies A, Browall M, Magri M, Selvekerova S, Madsen E, Milovics L, Bruyns I, Gudmundsdottir G, Hummerston S, Ahmad AMA, Platin N, Kearney N. Use of complementary and alternative medicine in cancer patients: a European survey. Annals of Oncol 2005, 16:655-663.
17. Ernst E, Cassileth BR. The prevalence of complementary/alternative medicine in cancer. Cancer 1998, 83(4):777-782. 10.1002/(SICI)1097-0142(19980815)83:4<777::AID-CNCR22>3.0.CO;2-O, 9708945.
18. Patterson RE, Neuhouser ML, Hedderson MM, et al. Types of alternative medicine used by patients with breast, colon, or prostate cancer: predictors, motives, and costs. J Altern Complement Med 2002, 8:477-485. 10.1089/107555302760253676, 12230908.
19. Downer SM, Cody MM, McCluskey P, Wilson PD, Arnott SJ, Lister TA, Slevin ML. Pursuit and practice of complementary therapies by cancer patients receiving conventional treatment. BMJ 1994, 309:86-89. 10.1136/bmj.309.6947.86, 2540590, 8038672.
20. Ceylan S, Hamazaoglu O, Komurcu S, Beyan C, Yalcin A. Survey of the use of complementary and alternative medicine among Turkish cancer patients. Complement Ther Med 2002, 10:94-99. 10.1054/ctim.2002.0527, 12481957.
21. Shen J, Wenger N, Glaspy J, et al. Electroacupuncture for control of myeloablative chemotherapy induced emesis: a randomized controlled trial. J Am Med Assoc 2000, 284:2755-2761.
22. Pan CX, Morrison RS, Ness J, et al. Complementary and alternative medicine in the management of pain, dyspneoa, and nausea and vomiting near end of life. a systematic review. J Pain Symptom Manage 2000, 20:374-387. 10.1016/S0885-3924(00)00190-1, 11068159.
23. Fellowes D, Barnes K, Wilkinson S. Aromatherapy and massage for symptom relief inpatients with cancer. Cochrane Database Syst Rev 2004, CD002287.
24. Glickman-Simon R. Complimentary and alternative medicine (CAM): an evidence-based approach. Medscape,2005 http://www.medscape.com/viewarticle/507242]accessed Aug 2006).
25. Ko RJ. Adulterants in Asian patent medicines. N England J Med 1998, 339:847.
26. Murch SJ, Krishna Raj S, Saxena PK. Phytopharmaceuticals: problems, limitations, and solutions. SciRev Alternat Med 2000, 4:33-37.
27. Drew AK, Myers SP. Safety Issues in herbal medicines: implications for the health professional. Med J Aust 1997, 166:538-541.
28. Ang-Lee MK, Moss J, Yuan CS. Herbal medicines and perioperative care. JAMA 2001, 286:208-216. 10.1001/jama.286.2.208, 11448284.
29. Gyasi RM, Mensah CM, Adjei PO, Agyeman S. Public perceptions of the role of traditional medicine in the health care delivery system in Ghana. Glob J Health Sci 2011, 3(2):40-49.
30. Lippman SM, Klein EA, Goodman PJ, et al. Effect of selenium and vitamin E on risk of prostate cancer and others: the Selinium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2009, 301(1):39-51. 10.1001/jama.2008.864, 19066370.
31. Davis EL, Oh B, Butow PN, Mullan BA, Clarke S. Cancer patient disclosure and patient-doctor communication of complementary and alternative medicine use: a systematic review. Oncologist 2012, 17(11):1475-1481. 10.1634/theoncologist.2012-0223, 22933591.
32. Kristoffersen AE, Fonnebo V, Northeim AJ. Do cancer patients with a por prognosis use complementary and alternative medicine more often than others?. J Altern Complement Med 2009, 14:1115-1120.
33. Raynor DK, Dickinson R, Knapp P, Long AF, Nicolson DJ. Buyer beware? Does the information provided with herbal products available over the counter enable safe use?. BMC Med 2011, 9:94. 10.1186/1741-7015-9-94, 3180693, 21827684.